Balaxi Pharmaceuticals has announced its 82nd Annual General Meeting (AGM) will be held virtually on August 25, 2025. Investors should note the agenda includes approving the audited standalone and consolidated financial results for the year ended March 31, 2025. Shareholders will also vote on the re-appointment of Director Mrs. Minoshi Maheshwari and the appointment of M/s. BVR & Associates Company Secretaries LLP as Secretarial Auditors for five years, at an annual fee of Rs. 55,000. This meeting is key for formalizing annual reports and corporate governance matters.